James Wang
Impact in
- Geriatrics and Gerontology top 2%
- Sirtuins and Resveratrol in Medicine
- Aging top 5%
Papers in
- Genetics 12
- Glioma Diagnosis and Treatment 6
- Chronic Lymphocytic Leukemia Research 5
- Hematology 10
- Multiple Myeloma Research and Treatments 8
- Co-authors
- David Sidransky (1 shared paper)Paul W. Ladenson (1 shared paper)Marge Ewertz (1 shared paper)Ralph Patrick Tufano (1 shared paper)Patrick J. Byrne (1 shared paper)Mingzhao Xing (1 shared paper)Shehzad Sultan Basaria (1 shared paper)Eli Rosenbaum (1 shared paper)
- Journals
- Bioorganic & Medicinal Chemistry Letters (5 papers)Blood (4 papers)ACS Medicinal Chemistry Letters (2 papers)Supportive Care in Cancer (2 papers)World Neurosurgery (2 papers)
- Partner nations
- United StatesChinaCanada
In The Last Decade
James Wang
49 papers receiving 2k citations
James Wang's Hit Papers
Peers
Comparison fields: 5 of 105
- Geriatrics and Gerontology 121
- Aging 51
- Genetics 142
- Endocrinology, Diabetes and Metabolism 211
- Molecular Biology 760
Countries citing papers authored by James Wang
This map shows the geographic impact of James Wang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by James Wang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites James Wang more than expected).
Fields of papers citing papers by James Wang
This network shows the impact of papers produced by James Wang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by James Wang. The network helps show where James Wang may publish in the future.
Co-authors
The 25 scholars most cited alongside James Wang, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 50 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Discovery of a Novel ERK Inhibitor with Activity in Models of Acquired Resistance to BRAF and MEK Inhibitors Hit paper breakdown → | 2013 | 568 |
| 2 | 2014 | 310 | |
| 3 | 2004 | 217 | |
| 4 | 2004 | 124 | |
| 5 | 2003 | 106 | |
| 6 | 1998 | 84 | |
| 7 | 2019 | 74 | |
| 8 | 2003 | 73 | |
| 9 | 2007 | 57 | |
| 10 | 2018 | 45 | |
| 11 | 2007 | 43 | |
| 12 | 2006 | 40 | |
| 13 | 2015 | 35 | |
| 14 | 2005 | 34 | |
| 15 | 2016 | 32 | |
| 16 | 2017 | 26 | |
| 17 | 2016 | 17 | |
| 18 | 2020 | 16 | |
| 19 | 2016 | 15 | |
| 20 | 2019 | 15 |
About James Wang
James Wang is a scholar working on Genetics, Hematology, Molecular Biology, Organic Chemistry and Computational Theory and Mathematics, having authored 50 papers that have together received 2.1k indexed citations. Recurring topics across this work include Multiple Myeloma Research and Treatments (8 papers), Protein Kinase Regulation and GTPase Signaling (6 papers), Glioma Diagnosis and Treatment (6 papers), Synthesis and biological activity (6 papers), Chronic Lymphocytic Leukemia Research (5 papers), Computational Drug Discovery Methods (3 papers), Melanoma and MAPK Pathways (3 papers) and Rheumatoid Arthritis Research and Therapies (2 papers). The work is most often cited by research in Geriatrics and Gerontology (121 citations), Aging (51 citations), Genetics (142 citations), Endocrinology, Diabetes and Metabolism (211 citations) and Molecular Biology (760 citations). James Wang has collaborated with scholars based in United States, China and Canada. Frequent co-authors include David Sidransky, Paul W. Ladenson, Marge Ewertz, Ralph Patrick Tufano, Patrick J. Byrne, Mingzhao Xing, Shehzad Sultan Basaria, Eli Rosenbaum, Anthony P. Tufaro and Selma Çetin. Their work appears in journals such as Bioorganic & Medicinal Chemistry Letters, Blood, ACS Medicinal Chemistry Letters, Supportive Care in Cancer and World Neurosurgery.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.